12.79
+0.79
+(6.58%)
At close: February 18 at 4:00:00 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
HOMCY CHARLES J Director | Conversion of Exercise of derivative security | Feb 3, 2025 | -- |
LIM JONATHAN E Director | Conversion of Exercise of derivative security | Feb 3, 2025 | -- |
THIRD ROCK VENTURES IV, L.P. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 3, 2025 | -- |
Related Tickers
MTSR Metsera, Inc.
32.08
+4.91%
SION Sionna Therapeutics, Inc.
20.04
+0.05%
ALMS Alumis Inc.
5.06
-2.88%
SEPN Septerna, Inc.
6.87
-46.99%
AARD Aardvark Therapeutics, Inc. Common Stock
13.56
+1.95%
AAPG Ascentage Pharma Group Internat
18.51
+1.48%
BCAX Bicara Therapeutics Inc.
13.09
-2.89%
UPB Upstream Bio, Inc.
8.40
+10.53%
RAPP Rapport Therapeutics, Inc.
14.04
-11.70%
MBX MBX Biosciences, Inc.
10.90
+4.71%